FGP
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
0.3
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
526
Howard Hughes
HHH
$4.08B
| $769K | 0.01% |
+12,157
| New | +$912K |
2026 Q1
0 quarters
|
|
527
Innospec
IOSP
$2.39B
| $768K | 0.01% |
10,511
-2,964
| -22% | -$231K |
2025 Q2
3 quarters
|
|
528
SLM Corp
SLM
$4.17B
| $762K | 0.01% |
+35,607
| New | +$842K |
2026 Q1
0 quarters
|
|
529
Krystal Biotech
KRYS
$9.79B
| $755K | 0.01% |
+2,922
| New | +$778K |
2026 Q1
0 quarters
|
|
530
Cathay General Bancorp
CATY
$3.94B
| $748K | 0.01% |
+15,008
| New | +$758K |
2026 Q1
0 quarters
|
|
531
Interparfums
IPAR
$3.67B
| $746K | 0.01% |
8,211
+5,080
| +162% | +$482K |
2025 Q3
2 quarters
|
|
532
MSC Industrial Direct
MSM
$7.4B
| $745K | 0.01% |
8,078
-18,928
| -70% | -$1.69M |
2025 Q4
1 quarter
|
|
533
Qualys
QLYS
$6.56B
| $744K | 0.01% |
+8,466
| New | +$938K |
2026 Q1
0 quarters
|
|
534
HUB Group
HUBG
$1.61B
| $743K | 0.01% |
+20,623
| New | +$871K |
2026 Q1
0 quarters
|
|
535
Camping World
CWH
$275M
| $742K | 0.01% |
108,646
+85,723
| +374% | +$883K |
2025 Q2
3 quarters
|
|
536
United Bankshares
UBSI
$6.23B
| $735K | 0.01% |
+17,751
| New | +$738K |
2026 Q1
0 quarters
|
|
537
Prestige Consumer Healthcare
PBH
$2.29B
| $733K | 0.01% |
+12,364
| New | +$802K |
2026 Q1
0 quarters
|
|
538
Werner Enterprises
WERN
$1.95B
| $729K | 0.01% |
24,792
+10,102
| +69% | +$327K |
2024 Q4
5 quarters
|
|
539
Upwork
UPWK
$1.05B
| $727K | 0.01% |
+66,301
| New | +$1.04M |
2026 Q1
0 quarters
|
|
540
RPC Inc
RES
$1.32B
| $719K | 0.01% |
+101,545
| New | +$632K |
2026 Q1
0 quarters
|
|
541
CBIZ
CBZ
$3.01B
| $716K | 0.01% |
+26,652
| New | +$940K |
2026 Q1
0 quarters
|
|
542
Zillow
Z
$6.37B
| $713K | 0.01% |
17,221
+13,352
| +345% | +$710K |
2025 Q4
1 quarter
|
|
543
Insperity
NSP
$1.89B
| $706K | 0.01% |
26,120
-1,288
| -5% | -$41.4K |
2025 Q2
3 quarters
|
|
544
Ellington Financial
EFC
$1.51B
| $696K | ﹤0.01% |
58,743
+5,293
| +10% | +$67.3K |
2025 Q2
3 quarters
|
|
545
Corteva
CTVA
$8.94B
| $690K | ﹤0.01% |
+8,238
| New | +$621K |
2026 Q1
0 quarters
|
|
546
Eversource Energy
ES
$25.1B
| $687K | ﹤0.01% |
+9,913
| New | +$701K |
2026 Q1
0 quarters
|
|
547
Ziff Davis
ZD
$1.97B
| $683K | ﹤0.01% |
16,270
+7,048
| +76% | +$259K |
2025 Q3
2 quarters
|
|
548
Cheesecake Factory
CAKE
$5.62B
| $683K | ﹤0.01% |
12,466
-3,134
| -20% | -$187K |
2025 Q3
2 quarters
|
|
549
The RealReal
REAL
$1.11B
| $677K | ﹤0.01% |
+74,512
| New | +$943K |
2026 Q1
0 quarters
|
|
550
Universal Corp
UVV
$1.01B
| $676K | ﹤0.01% |
+12,836
| New | +$691K |
2026 Q1
0 quarters
|
|
Similar funds
ECM
MIFH
GF
AIM
OTPPB
AA
IWC
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.